StatSure and Chembio Agree to End Litigation and Enter Agreement to Commercialize HIV Barrel Technology
StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) and Chembio Diagnostics, Inc. (OTC Bulletin Board: CEMI) announced today that they have entered into a series of agreements that provide Inverness Medical Innovations, Inc. (Amex: IMA) with exclusive worldwide marketing rights to Chembio’s FDA-cleared, point of care, rapid, SURE CHECK(R) HIV 1/2 product for the detection of HIV 1 & 2 antibodies. This test utilizes StatSure’s patented barrel technology, designed to provide convenient, safe, accurate and integrated single-use, rapid HIV antibody screening, and to minimize exposure to infectious agents; it will be exclusively manufactured by Chembio for Inverness’ distribution.
Inverness Medical Innovations, Chembio Diagnostics, Inc. and StatSure Diagnostic Systems, Inc. Announce Agreements to Market Rapid HIV and Other Tests
Inverness Medical Innovations, Inc. (Amex: IMA), Chembio Diagnostics, Inc. (OTCBB:CEMI), and StatSure Diagnostic Systems, Inc. (OTCBB:SSUR) announced today that they had entered into a series of agreements that provide Inverness with exclusive worldwide marketing rights to Chembio’s FDA-cleared, point of care, rapid test for the detection of antibodies to HIV. The test utilizes Inverness’ proprietary lateral flow technology as well as StatSure’s patented “barrel” technology designed to maximize ease of use and minimize exposure to infectious agents.
Read full releases here:
http://stockguru.com/profiles/ssur/news.php
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $24,000 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
